Paratek Pharmaceuticals
Overview
We are a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. Our United States, or U.S., Food and Drug Administration, or FDA, approved commercial product, NUZYRA (omadacycline) is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, or CABP, and acute skin and skin structure infections, or ABSSSI, caused by susceptible pathogens.
Divisions & what they sell
A rep inherits the attributes of their division, not the company — “worked at Paratek Pharmaceuticals” means something different in each of these.
Pharmaceuticals
Verified · SEC 10-K segments- Call point
- infectious disease specialist
- Sales motion
- detailing
- Reimbursement
- specialty pharmacy
Products
Competes with
Where a rep in this division can realistically move.